Bivalent vaccine in Canada: Pfizer’s Omicron shot authorized



Health Canada says Canadians ages 12 and up can now be given the Pfizer-BioNTech COVID-19 booster vaccine that targets the BA.4 and BA.5 strains of the Omicron variant.

Health Minister Jean-Yves Duclos and Health Canada officers are scheduled to debate the approval in element later right now.

The authorization says the vaccine will be given three to 6 months after a second dose of the first vaccine collection, or the newest booster shot.

It is the second mixture vaccine greenlighted by Health Canada’s vaccine overview group, however the first that targets the virus strains that at the moment are commonest in Canada.

The Moderna mixture shot authorized 5 weeks in the past targets the unique virus and the primary Omicron variant, whereas the Pfizer shot authorized right now targets the BA.4 and BA.5 strains.

Health Canada says 88 per cent of the COVID-19 instances recognized in mid-September have been BA.5 and 9 per cent have been BA.4.


Please enter your comment!
Please enter your name here